Hajiha Mohammad, DuBord Marq-André, Liu Hattie, Horner Richard L
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
J Physiol. 2009 Jun 1;587(Pt 11):2677-92. doi: 10.1113/jphysiol.2009.171678. Epub 2009 Apr 29.
Opioids can modulate breathing and predispose to respiratory depression by actions at various central nervous system sites, but the mechanisms operating at respiratory motor nuclei have not been studied. This study tests the hypotheses that (i) local delivery of the mu-opioid receptor agonist fentanyl into the hypoglossal motor nucleus (HMN) will suppress genioglossus activity in vivo, (ii) a component of this suppression is mediated by opioid-induced acetylcholine release acting at muscarinic receptors, and (iii) delta- and kappa-opioid receptors also modulate genioglossus activity. Seventy-two isoflurane-anaesthetised, tracheotomised, spontaneously breathing rats were studied during microdialysis perfusion into the HMN of (i) fentanyl and naloxone (mu-opioid receptor antagonist), (ii) fentanyl with and without co-application of muscarinic receptor antagonists, and (iii) delta- and kappa-opioid receptor agonists and antagonists. The results showed (i) that fentanyl at the HMN caused a suppression of genioglossus activity (P < 0.001) that reversed with naloxone (P < 0.001), (ii) that neither atropine nor scopolamine affected the fentanyl-induced suppression of genioglossus activity, and (iii) that delta-, but not kappa-, opioid receptor stimulation also suppressed genioglossus activity (P = 0.036 and P = 0.402 respectively). We conclude that mu-opioid receptor stimulation suppresses motor output from a central respiratory motoneuronal pool that activates genioglossus muscle, and this suppression does not involve muscarinic receptor-mediated inhibition. This mu-opioid receptor-induced suppression of tongue muscle activity by effects at the hypoglossal motor pool may underlie the clinical concern regarding adverse upper airway function with mu-opioid analgesics. The inhibitory effects of mu- and delta-opioid receptors at the HMN also indicate an influence of endogenous enkephalins and endorphins in respiratory motor control.
阿片类药物可通过作用于中枢神经系统的多个部位来调节呼吸并导致呼吸抑制,但在呼吸运动核团起作用的机制尚未得到研究。本研究检验了以下假设:(i)将μ-阿片受体激动剂芬太尼局部注入舌下运动核(HMN)会在体内抑制颏舌肌活动;(ii)这种抑制的一部分是由阿片类药物诱导的乙酰胆碱释放作用于毒蕈碱受体介导的;(iii)δ-和κ-阿片受体也调节颏舌肌活动。在向HMN进行微透析灌注期间,对72只异氟烷麻醉、气管切开、自主呼吸的大鼠进行了研究,灌注的药物包括:(i)芬太尼和纳洛酮(μ-阿片受体拮抗剂);(ii)芬太尼,同时应用和不应用毒蕈碱受体拮抗剂;(iii)δ-和κ-阿片受体激动剂和拮抗剂。结果显示:(i)HMN处的芬太尼导致颏舌肌活动受到抑制(P < 0.001),而纳洛酮可使其逆转(P < 0.001);(ii)阿托品和东莨菪碱均不影响芬太尼诱导的颏舌肌活动抑制;(iii)δ-阿片受体刺激可抑制颏舌肌活动(P = 0.036),而κ-阿片受体刺激则无此作用(P = 0.402)。我们得出结论,μ-阿片受体刺激会抑制激活颏舌肌的中枢呼吸运动神经元池的运动输出,且这种抑制不涉及毒蕈碱受体介导的抑制。μ-阿片受体通过作用于舌下运动池对舌肌活动产生的这种抑制作用,可能是临床上对μ-阿片类镇痛药引起上呼吸道功能不良表示担忧的原因。μ-和δ-阿片受体在HMN处的抑制作用也表明内源性脑啡肽和内啡肽在呼吸运动控制中具有影响。